Shoukhrat Mitalipov, Ph.D., and Paula Amato, M.D., provide context on a new effort to allow mitochondrial replacement therapy, a technique developed at OHSU, to move to clinical trials in the U.S.
Researchers at the Pacific Northwest Evidence Based Practice Center have determined that current clinical prediction tools and patient questionnaires are not effective in identifying the risk of potential blood lead exposure in the children and pregnant women. The study, published in JAMA, informs new recommendations from the U.S. Preventative Services Task Force.
Sunil Joshi, OHSU M.D./Ph.D. candidate and researcher in the Druker lab, is named a 2019 Paul & Daisy Soros Fellow for New Americans, and is one of five Indian American students awarded the distinction.
New research reveals the native structure of the AMPA receptor, a critical receptor in the brain associated with learning, memory, behavior and mood. “If these switches don’t work right, then the brain doesn’t function. It can lead to seizures, memory loss, and neurodegenerative conditions like Alzheimer’s disease,” says Eric Gouaux, Ph.D.